Entera Bio Ltd. — Director's Dealing 2023

Apr 25, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2023-04-24

Reporting Person: Santora Arthur C II (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-24	Stock Option (right to buy)	$0.795	A	35000	Acquired	2033-04-24	Ordinary Shares, par value NIS 0.0000769 per share (35000)	Direct

Footnotes

F1: The options vest over a four-year period with 25% of the options vesting on April 24, 2024, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.